← All indications
Febrile Neutropenia
Fever accompanied by a significant reduction in the number of NEUTROPHILS.
Subtype terms (1)
More specific conditions that are subtypes of Febrile Neutropenia in the MeSH hierarchy.
- Chemotherapy-Induced Febrile Neutropenia
4 drugs approved
Drugs by status
Approved for this indication (2)
Phase 4 trials (19)
Phase 3 trials (5)
Phase 2 trials (12)
Phase 1 trials (1)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (19)
- Gilead Sciences
- Merck
- Sanofi
- ZonMw: The Netherlands Organisation for Health Research and Development
- Michigan State University
- Minsk State Clinical Hospital No 9
- Nanjing Medical University
- University of Ottawa
- Prince of Songkla University
- Tel Aviv University
- Belarusian State Medical University
- University of Indonesia
- University of Amsterdam
- Free University of Amsterdam
- University of Barcelona
- University of Mississippi
- Fonds NutsOhra
- Chinese Academy of Medical Sciences
- Universidad Carlos III Madrid
Organization Involved with Phase 3 Indications (15)
- Pfizer
- Mylan
- Bayer
- Cubist
- Hengrui Therapeutics, Inc.
- Huazhong University of Science and Technology
- Maastricht University
- Nagoya University
- University of Liverpool
- University of Rochester
- Peking University
- Janssen Pharmaceutica NV
- Johnson and Johnson
- People's Liberation Army of China
- Center for Supporting Hematology-Oncology Trials
Organization Involved with Phase 2 Indications (18)
- Forest Laboratories
- Allergan
- Kyowa Hakko Kirin
- S&D Pharma SK s.r.o.
- The Foundation Institute San Raffaele G. Giglio of Cefalù
- National Polytechnic Institute, Mexico
- Slovak Academy of Sciences
- Cornell University
- Gruppo Italiano Trapianto di Midollo Osseo
- Yonsei University
- University of Ulsan
- Enzychem Lifesciences
- Jiao Tong University
- University Children's Hospital Banska Bystrica
- Abecma
- Government of Mexico
- Free University of Brussels
- National Autonomous University of Mexico
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (2)